Introducing JLK BIO
JLK BIO is highly committed to make human life healthier and happier through fast and smart drug discovery and development using AI. DeepHits™ is an AI platform of JLK BIO, featured by our unique model called "Universal Encoder" which maps semantic features of chemicals to information-rich representation in “JLK BIO Chemical Space”.
Along with our state-of-the-art AI technology, we understand irreplaceable roles of human in decision making; In this regard, we are very proud of our team consisted of experts with wide and deep knowledge and abundant experiences in diverse fields. Everyone in the team has shown the talents and remarkable track records in their own specialties.
JLK BIO aims to find promising new drug candidates through open innovation and DeepHits™. As a member of JLK Group, JLK BIO will keep challenge beyond possibility for the good of all humantiy.
Our Mission
We challenge ourselves to make human life healthier and happier through fast and smart drug discovery and development using artificial intelligence (AI) on top of collaborative open innovation.
Our Vision
We aim to be the number one AI driven innovative biotech company standing out among global AI companies in drug discovery and development. As a leading AI biotech company, we are looking forward to being the best partner of scientists by complementing their capacity in developing innovative drug candidates and, therefore, leading to commercial success.
Scientific Advisory Board
Nam Ik Cho
Artificial Intelligence
Sung Hee Um
Molecular Cell Biology
Tae Moo Yoo
Regulatory Affair
Young Kee Shin
Pathology
In Su Kim
Medicinal Chemistry
Jung Hoon Lee
Patent Attorney
Sun Kil Ahn
Medicinal Chemistry
Gyu Bong Kim
Toxicology
Values of JLK BIO
